Skip to main content
. 2010 Sep 8;5(9):e12244. doi: 10.1371/journal.pone.0012244

Table 2. Folate and vitamin B12 markers in plasma before and after 2 years of intervention in the MRI subgroup.

Placebo group Active treatment groupa
N Geometric mean 95% C.I. N Geometric mean 95% C.I. P value b
tHcy Before 83 11.27 (10.58–12.00) 85 11.25 (10.58–11.97) 0.974
(µmol/L) After 83 12.14 (11.40–12.93) 84 8.72 (8.29–9.17) <0.001
P value c <0.001 <0.001
Folate (nmol/L) Before 83 24.2 (21.4–27.5) 85 22.4 (19.4–25.9) 0.428
After 83 24.9 (21.4–29.1) 84 82.1 (74.6–90.4) <0.001
P value c 0.695 <0.001
Vitamin B12 (pmol/L) Before 83 333 (310–357) 85 330 (303–360) 0.891
After 83 366 (335–400) 84 672 (626–722) <0.001
P value c 0.018 <0.001
HoloTC (pmol/L) Before 83 68 (61–76) 85 63 (55–72) 0.406
After 83 73 (65–82) 84 182 (162–204) <0.001
P value c 0.116 <0.001
TC saturation (%) Before 83 7.35 (6.54–8.25) 85 6.65 (5.72–7.73) 0.306
After 83 7.17 (6.26–8.21) 84 20.42 (18.21–22.90) <0.001
P value c 0.648 <0.001
Cystathionine Before 83 0.303 (0.273–0.337) 85 0.265 (0.237–0.295) 0.082
(µmol/L) After 83 0.350 (0.311–0.395) 84 0.215 (0.196–0.235) <0.001
P value c 0.002 <0.001

Abbreviations: HoloTC, holotranscobalamin; TC saturation, ratio of holoTC to total TC; tHcy, plasma total homocysteine.

a

Active treatment group received daily supplements of folic acid (0.8 mg), vitamin B12 (0.5 mg) and vitamin B6 (20 mg) for 24 months.

b

Student's t-test for unpaired samples,

c

Student's t-test for paired samples.